Fund profile
Tickers
PHPIX, PHPSX
Fund manager
Total assets
$3.36 mm
Liabilities
$2.69 k
Net assets
$3.36 mm
Number of holdings
43.00
43 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
SOCIETE GENERALE | 267.00 k | 267.00 k principal | 7.94 | Repurchase agreement | Long | USA |
HSBC SECURITIES USA INC | 160.00 k | 160.00 k principal | 4.76 | Repurchase agreement | Long | USA |
OGN Organon & Co. | 152.91 k | 9.18 k shares | 4.55 | Common equity | Long | USA |
CTLT Catalent Inc. | 140.51 k | 2.72 k shares | 4.18 | Common equity | Long | USA |
CREDIT AGRICOLE CIB NY | 132.00 k | 132.00 k principal | 3.93 | Repurchase agreement | Long | USA |
AXSM Axsome Therapeutics Inc | 129.73 k | 1.44 k shares | 3.86 | Common equity | Long | USA |
VTRS Viatris Inc | 121.16 k | 10.29 k shares | 3.60 | Common equity | Long | USA |
MRK Merck & Co Inc | 117.76 k | 975.00 shares | 3.50 | Common equity | Long | USA |
ELAN Elanco Animal Health Inc | 116.53 k | 7.91 k shares | 3.47 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 113.00 k | 1.68 k shares | 3.36 | Common equity | Long | USA |
ROYAL BANK OF CANADA | 111.00 k | 111.00 k principal | 3.30 | Repurchase agreement | Long | USA |
Natwest Markets PLC | 111.00 k | 111.00 k principal | 3.30 | Repurchase agreement | Long | USA |
PRGO Perrigo Company plc | 109.46 k | 3.41 k shares | 3.26 | Common equity | Long | Ireland |
LLY Lilly(Eli) & Co | 108.46 k | 168.00 shares | 3.23 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 107.02 k | 4.55 k shares | 3.18 | Common equity | Long | USA |
JNJ Johnson & Johnson | 104.08 k | 655.00 shares | 3.10 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 103.08 k | 840.00 shares | 3.07 | Common equity | Long | Ireland |
ZTS Zoetis Inc - Ordinary Shares | 102.92 k | 548.00 shares | 3.06 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 100.56 k | 3.54 k shares | 2.99 | Common equity | Long | UK |
BMY Bristol-Myers Squibb Co. | 98.23 k | 2.01 k shares | 2.92 | Common equity | Long | USA |
PFE Pfizer Inc. | 95.21 k | 3.52 k shares | 2.83 | Common equity | Long | USA |
UMB FINANCIAL CORP | 92.00 k | 92.00 k principal | 2.74 | Repurchase agreement | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 72.42 k | 4.53 k shares | 2.15 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 57.43 k | 1.82 k shares | 1.71 | Common equity | Long | USA |
SAVA Cassava Sciences Inc | 52.59 k | 2.20 k shares | 1.56 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 49.50 k | 1.52 k shares | 1.47 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals Inc | 47.86 k | 897.00 shares | 1.42 | Common equity | Long | USA |
CORT Corcept Therapeutics Inc | 43.82 k | 2.08 k shares | 1.30 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc | 41.72 k | 678.00 shares | 1.24 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 35.53 k | 7.06 k shares | 1.06 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 34.08 k | 1.25 k shares | 1.01 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals Inc | 34.07 k | 1.23 k shares | 1.01 | Common equity | Long | USA |
ARVN Arvinas Inc | 31.08 k | 749.00 shares | 0.92 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 29.46 k | 1.64 k shares | 0.88 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals Inc | 29.19 k | 523.00 shares | 0.87 | Common equity | Long | USA |
INVA Innoviva Inc | 27.15 k | 1.68 k shares | 0.81 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 22.94 k | 696.00 shares | 0.68 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 20.25 k | 277.00 shares | 0.60 | Common equity | Long | USA |
AMRX Amneal Pharmaceuticals Inc - Ordinary Shares | 15.62 k | 2.92 k shares | 0.46 | Common equity | Long | USA |
EOLS Evolus Inc | 15.38 k | 1.21 k shares | 0.46 | Common equity | Long | USA |
TBPH Theravance Biopharma Inc | 10.43 k | 1.10 k shares | 0.31 | Common equity | Long | Cayman Islands |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX
UBS SECURITIES LLC
|
-1.84 k | 265.00 other units | -0.05 | Equity derivative | N/A | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX
GOLDMAN SACHS GROUP, INC
|
-10.80 k | 229.00 other units | -0.32 | Equity derivative | N/A | USA |